{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:55:58Z","timestamp":1791741358713,"version":"4.3.4"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50631-0"],"award-info":[{"award-number":["2014\/50631-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/17471-7"],"award-info":[{"award-number":["2017\/17471-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00843","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T13:15:06Z","timestamp":1556111706000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine"],"prefix":"10.3389","volume":"10","author":[{"given":"Juliana de Souza","family":"Apost\u00f3lico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vict\u00f3ria Alves Santos","family":"Lunardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Massao","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edecio","family":"Cunha-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Beatriz","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Santoro","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.immuni.2008.08.008","article-title":"In vivo induction of immune responses to pathogens by conventional dendritic cells","volume":"29","author":"Lopez-Bravo","year":"2008","journal-title":"Immunity."},{"key":"B2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fimmu.2014.00255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"Cohn","year":"2014","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.4049\/jimmunol.179.10.6704","article-title":"Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation","volume":"179","author":"Sarkar","year":"2007","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri1996","article-title":"Steady-state and inflammatory dendritic-cell development","volume":"7","author":"Shortman","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nri2103","article-title":"Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo","volume":"7","author":"Villadangos","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.0105-2896.2009.00888.x","article-title":"Features of the dendritic cell lineage","volume":"234","author":"Steinman","year":"2010","journal-title":"Immunol Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.163.4.981","article-title":"Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody","volume":"163","author":"Kraal","year":"1986","journal-title":"J Exp Med."},{"key":"B12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/cimm.1995.1109","article-title":"Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145","volume":"163","author":"Inaba","year":"1995","journal-title":"Cell Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"16270","DOI":"10.1073\/pnas.1208796109","article-title":"DEC-205 is a cell surface receptor for CpG oligonucleotides","volume":"109","author":"Lahoud","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e23128","DOI":"10.4161\/onci.23128","article-title":"DEC-205 is a cell surface receptor for CpG oligonucleotides","volume":"2","author":"Caminschi","year":"2013","journal-title":"Oncoimmunology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"869718","DOI":"10.1155\/2013\/869718","article-title":"Targeting antigens to dendritic cell receptors for vaccine development","volume":"2013","author":"Apostolopoulos","year":"2013","journal-title":"J Drug Deliv."},{"key":"B18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nri3727","article-title":"Dendritic cell-targeted vaccines\u2013hope or hype?","volume":"14","author":"Kastenmuller","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7774\/cevr.2014.3.2.149","article-title":"Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo","volume":"3","author":"Park","year":"2014","journal-title":"Clin Exp Vaccine Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin Transl Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.20052005","article-title":"Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine","volume":"203","author":"Trumpfheller","year":"2006","journal-title":"J Exp Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/eji.201040511","article-title":"Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague","volume":"40","author":"Do","year":"2010","journal-title":"Eur J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fimmu.2018.00317","article-title":"Targeted delivery of Toxoplasma gondii antigens to dendritic cells promote immunogenicity and protective efficiency against toxoplasmosis","volume":"9","author":"Lakhrif","year":"2018","journal-title":"Front Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1084\/jem.20051639","article-title":"Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses","volume":"203","author":"Boscardin","year":"2006","journal-title":"J Exp Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1182\/blood-2011-10-388579","article-title":"Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates","volume":"119","author":"Kwissa","year":"2012","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"P716","DOI":"10.1016\/j.it.2016.08.005","article-title":"Triggering intracellular receptors for vaccine adjuvantation","volume":"37","author":"Gutjahr","year":"2016","journal-title":"Trends Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/COH.0000000000000365","article-title":"Adjuvants: tailoring humoral immune responses","volume":"12","author":"McElrath","year":"2017","journal-title":"Curr Opin HIV AIDS."},{"key":"B31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000086657","article-title":"TLR signalling and the function of dendritic cells","volume":"86","author":"Hemmi","year":"2005","journal-title":"Chem Immunol Allergy."},{"key":"B32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Exp Rev Vaccines."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2330","DOI":"10.1371\/journal.pntd.0002330","article-title":"Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge","volume":"7","author":"Henriques","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0117778","DOI":"10.1371\/journal.pone.0117778","article-title":"Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen","volume":"10","author":"Rampazo","year":"2015","journal-title":"PLoS ONE."},{"key":"B35","unstructured":"Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and alphaDEC-CSP in non human primates725666\n            TewariK\n            FlynnBJ\n            BoscardinSB\n            KastenmuellerK\n            SalazarAM\n            AndersonCA\n          10.1016\/j.vaccine.2010.08.09820846528Vaccine.282010"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39250","DOI":"10.1038\/srep39250","article-title":"The presence of T cell epitopes is important for induction of antibody responses against antigens directed to DEC205(+) dendritic cells","volume":"6","author":"Amorim","year":"2016","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0124828","DOI":"10.1371\/journal.pone.0124828","article-title":"ESAT-6 targeting to DEC205+ Antigen presenting cells induces specific-T cell responses against ESAT-6 and reduces pulmonary infection with virulent Mycobacterium tuberculosis","volume":"10","author":"Silva-Sanchez","year":"2015","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1073\/pnas.0711976105","article-title":"The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine","volume":"105","author":"Trumpfheller","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fimmu.2017.00101","article-title":"Dendritic cell targeting effectively boosts T cell responses elicited by an HIV multiepitope DNA vaccine","volume":"8","author":"Apostolico","year":"2017","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1182\/blood-2008-03-148072","article-title":"Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses","volume":"112","author":"Gurer","year":"2008","journal-title":"Blood."},{"key":"B41","doi-asserted-by":"publisher","first-page":"232ra251","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci Transl Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-17-1792","article-title":"NY-ESO-1 vaccination in combination with decitabine induces antigen-specific T-lymphocyte responses in patients with myelodysplastic syndrome","volume":"24","author":"Griffiths","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1189\/jlb.0305172","article-title":"The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells","volume":"78","author":"Thompson","year":"2005","journal-title":"J Leukoc Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e56855","DOI":"10.1371\/journal.pone.0056855","article-title":"TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion","volume":"8","author":"Gandhapudi","year":"2013","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the adjuvant system story","volume":"13","author":"Garcon","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.4049\/jimmunol.170.6.3059","article-title":"The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets","volume":"170","author":"Hemmi","year":"2003","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2004.02.022","article-title":"Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides","volume":"97","author":"Mutwiri","year":"2004","journal-title":"J Control Release."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1517\/14712598.7.11.1731","article-title":"Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy","volume":"7","author":"Barry","year":"2007","journal-title":"Expert Opin Biol Ther."},{"key":"B50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-804019-5.00009-8","article-title":"CpG Oligodeoxynucleotides as adjuvants for clinical use","volume-title":"Immunopotentiators in Modern Vaccines","author":"Shirota","year":"2017"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20090247","article-title":"Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant","volume":"206","author":"Longhi","year":"2009","journal-title":"J Exp Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3389\/fimmu.2017.01727","article-title":"CpG oligodeoxinucleotides and flagellin modulate the immune response to antigens targeted to CD8alpha(+) and CD8alpha(-) conventional dendritic cell subsets","volume":"8","author":"Antonialli","year":"2017","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0145637","DOI":"10.1371\/journal.pone.0145637","article-title":"HIV envelope trimer specific immune response is influenced by different adjuvant formulations and heterologous prime-boost","volume":"11","author":"Apostolico Jde","year":"2016","journal-title":"PLoS ONE."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e16921","DOI":"10.1371\/journal.pone.0016921","article-title":"A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses","volume":"6","author":"Rosa","year":"2011","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.20032220","article-title":"In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination","volume":"199","author":"Bonifaz","year":"2004","journal-title":"J Exp Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science."},{"key":"B57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/14760584.6.5.673","article-title":"The science of adjuvants","volume":"6","author":"Kwissa","year":"2007","journal-title":"Expert Rev Vaccines."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1459394","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: classification, modus operandi, and licensing","volume":"2016","author":"Apostolico Jde","year":"2016","journal-title":"J Immunol Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1182\/blood-2010-06-288068","article-title":"Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody","volume":"116","author":"Cheong","year":"2010","journal-title":"Blood."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1073\/pnas.1103869108","article-title":"Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates","volume":"108","author":"Flynn","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1073\/pnas.1019547108","article-title":"Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A","volume":"108","author":"Idoyaga","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/mi.2015.133","article-title":"A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract","volume":"9","author":"Ruane","year":"2016","journal-title":"Mucosal Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-2567.2010.03265.x","article-title":"Regulation of CD4 T-cell receptor diversity by vaccine adjuvants","volume":"130","author":"Baumgartner","year":"2010","journal-title":"Immunology."},{"key":"B64","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med."},{"key":"B65","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"Curtsinger","year":"2005","journal-title":"J Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.4049\/jimmunol.176.6.3315","article-title":"Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection","volume":"176","author":"Havenar-Daughton","year":"2006","journal-title":"J Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4049\/jimmunol.1003166","article-title":"Type I IFN substitutes for T cell help during viral infections","volume":"186","author":"Wiesel","year":"2011","journal-title":"J Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/eji.201142091","article-title":"Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo","volume":"42","author":"Wiesel","year":"2012","journal-title":"Eur J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J Exp Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","article-title":"Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy","volume":"103","author":"Harari","year":"2004","journal-title":"Blood."},{"key":"B72","doi-asserted-by":"publisher","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiencyvirus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2010.09.011","article-title":"Induction of immunity to human immunodeficiency virus type-1 by vaccination","volume":"33","author":"McElrath","year":"2010","journal-title":"Immunity."},{"key":"B74","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4172\/2155-9899.1000518","article-title":"Conserved HIV epitopes for an effective HIV vaccine","volume":"8","author":"Sahay","year":"2017","journal-title":"J Clin Cell Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1128\/JVI.00272-09","article-title":"Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge","volume":"83","author":"Wilson","year":"2009","journal-title":"J Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fimmu.2018.00177","article-title":"Propionibacterium acnes enhances the immunogenicity of HIVBr18 human immunodeficiency virus-1 vaccine","volume":"9","author":"Teixeira","year":"2018","journal-title":"Front Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2249.2008.03856.x","article-title":"High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination","volume":"155","author":"Wang","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1128\/IAI.71.5.2498-2507.2003","article-title":"Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A","volume":"71","author":"Martin","year":"2003","journal-title":"Infect Immun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/eji.200323797","article-title":"Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines","volume":"33","author":"Edwards","year":"2003","journal-title":"Eur J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T13:15:10Z","timestamp":1556111710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":80,"alternative-id":["10.3389\/fimmu.2019.00843"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00843","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"article-number":"843"}}